Adjuvant therapy for colon cancer: genes, genes... and the patient in the center
Rodriguez J (1), Vicent S (2), Chopitea A (1), Ponz-Sarvise M (3).
(1) Medical Oncology, Clinica Universidad de Navarra, University of Navarra.
(2) Program of Solid Tumors, Center for Applied Medical Research (CIMA), University of Navarra.
(3) Medical Oncology, Clinica Universidad de Navarra/Center for Applied Medical Research (CIMA), University of Navarra email@example.com.
Magazine: Clinical Cancer Research
Date: Apr 20, 2018Medical Oncology
Although molecular subtype-based stratification and genomic signatures of increasing complexity are becoming a new strategy to guide therapeutic decisions in stage II/III colon cancer, several prognostic factors that can be easily obtained from FFPE specimens should be considered in order to create combined models that better define individual patients needs.
CITATION Clin Cancer Res. 2018 Apr 20. pii: clincanres.0818.2018. doi: 10.1158/1078-0432.CCR-18-0818
you mayBE INTERESTED
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.